The Lab of the Future in Numbers: 40+ Statistics on Automation, AI, and the Digital Lab (2026)

The lab automation market is heading toward USD 24 billion by the mid-2030s. Yet only 6% of quality-control labs run at a predictive, AI-augmented maturity level today.

I think this pretty much sums up the whole story of the lab of the future: huge momentum, but uneven reality.

So in this article I’ve pulled a few key “lab of the future” statistics for you. 

Every statistic comes from a market report, a peer-reviewed study, or a named industry survey, and I’ve linked the source. Where independent firms disagree, I give you the range instead of the best figure. 

Before we start, please subscribe to the BestLabTech newsletter. Every week we send a curated list of the most useful tools, resources, and reads from across the lab tech world. Enter your email below to subscribe.

You may also like:

• 5 Best Lab Workflow Software Tools
  
• Why LIMS Implementations Still Fail Today
  
• What is Lab Automation?

Lab of the Future Statistics: The Top Picks

Short on time? These are the seven strongest, most quotable numbers in the roundup. 

1. 77% of life sciences labs expect to use AI within two years 
2. AI is the number one lab investment area at 63%, stable for the third year running 
3. Total laboratory automation cut discrete manual processing steps by 86%
4. ELN adoption jumped to 81% in 2025, up from 66% a year earlier 
5. 80% of labs now use cloud data platforms, up from 70% in 2023 
6. Total lab automation improved turnaround-time predictability by 70% and paid back in about 4.75 years 
7. Only 6% of QC labs operate at a predictive, AI-augmented maturity level today 

Lab Automation Market Size and Growth Statistics

Ask eight research firms how big the lab automation market is and you get eight answers. 

Scope and methodology differ, so I’ve listed each below so you get the full range.

The consensus band: 

Roughly USD 6.6B–10B in 2025/26, forecast to USD 8.6B–24B by the early-to-mid 2030s, with CAGRs from 4.9% to 10.4% 

Firm by firm:

Table 1: Market size according to research firms

Sources: Fortune Business Insights, SNS Insider, Precedence Research, Grand View Research, MarketsandMarkets

Regional splits from IMARC Group:

• US: USD 3.08B (2025) to USD 5.08B (2034), a 5.71% CAGR
  
• Europe: USD 1.92B (2025) to USD 3.17B (2033), a 6.5% CAGR
  
• Asia Pacific: USD 978.7M (2025) to USD 1,826.1M (2034), a 6.96% CAGR 

Source: IMARC Group

Adjacent segments in the lab of the future economy:

• Laboratory informatics: USD 3.74B (2025) to USD 6.08B (2031), an 8.46% CAGR
  
• LIMS: forecast to reach USD 3.56B by 2030, a 6.22% CAGR
  
• AI in drug discovery: USD 6.93B (2025) to USD 16.52B (2034), a 10.10% CAGR
  
• Laboratory robotics: USD 2.93B (2026) to USD 5.12B (2034), a 7.22% CAGR

Sources: Mordor Intelligence, Grand View Research, Precedence Research, Fortune Business Insights

Lab Automation ROI: Speed, Efficiency, and Error-Reduction Statistics

Vendors love to claim automation pays for itself. 

The peer-reviewed clinical literature actually proves it. 

These are the hardest numbers in the piece, pulled from published studies rather than sales decks.

From a 2025 PMC review of total lab automation:

• Total lab automation cut discrete manual processing steps by 86% and reduced the testing footprint by 45%
  
• Test productivity per capita rose by up to 42% after total lab automation
  
• Tests performed per worker increased 1.4 to 3.7-fold in a Saudi hospital case study
  
• 95% of automated tests were reported in under 120 minutes
  
• The top five vendors held roughly 93% of global lab automation revenue in 2022 

Sources: PMC

The strongest single dataset is an economic evaluation from a tertiary hospital, published in Annals of Laboratory Medicine:

• Mean turnaround time fell 6.1%, worst-case (99th percentile) turnaround time fell 13.3%, turnaround predictability improved 70.0%, and staff tube-touch moments dropped 77.6%
  
• Capital paid back in about 4.75 years (range 3.54–6.24), with projected six-year savings of USD 1.88M and a 2.5–3.0 FTE reduction

Sources: Annals of Laboratory Medicine

And on the survey side, executives report real gains:

• 53% of biopharma executives saw increased lab throughput
  
• 45% saw reduced human error from lab modernization
  
• In a Siemens Healthineers survey of 408 US lab professionals, 89% said their labs need automation to keep up with demand 

Sources: Deloitte, The Harris Poll for Siemens Healthineers

AI in the Lab of the Future: Adoption and Impact Statistics

AI is the defining force of the lab of the future, and the widest gap between intent and reality in the whole dataset. Labs want it badly… but few have deployed it at scale.

The intent side is overwhelming:

• 77% of life sciences labs expect to use AI within two years
• AI is the number one lab investment area at 63%, stable for the third year running
• AI computing power surged over 1000x from 2016 to 2024

Sources: Pistoia Alliance, PMC

But in reality:

• Only 6% of QC labs operate at a predictive, AI-augmented maturity level, and 40% remain digitally siloed

Sources: Deloitte

In R&D, where AI is further along, the measured impact is large:

• Boston Consulting Group projects AI-enabled workflows can cut time to a preclinical drug candidate by 30–50% and lower costs by up to 50%
  
• AI achieved over 75% hit validation in virtual drug screening
  
• Over 80% of pathologists support AI-assisted diagnostic systems in clinical diagnostics 

Sources: Boston Consulting Group, PMC

The Digital Lab: LIMS, ELN, Cloud, and Data Statistics

The paperless, cloud-connected lab is arriving fast, and the Pistoia Alliance survey gives clean year-over-year deltas to prove it. The catch: the data underneath is still a mess.

Adoption is climbing sharply:

• 80% of labs now use cloud data platforms, up from 70% in 2023
  
• ELN adoption rose to 81% in 2025, up from 66% in 2024
  
• Data silos remain the top data challenge at 57%, down 9 points since 2023

Sources: Pistoia Alliance

Also, more than 1 in 4 labs don’t know what data their AI or LLM tools use, and only about 1 in 3 regularly feed proprietary lab data into models

From TetraScience and Pharma IQ, using 2022 survey data, 74% of biopharma organizations are moving scientific data to the cloud, 87% find DIY point-to-point integrations burdensome, bench scientists spend 49% of their time on manual data retrieval and cleansing, and about 50% say under half their data is FAIR.

Sources: Pistoia Alliance, TetraScience & Pharma IQ, 2022

Finally, Deloitte’s R&D maturity model shows how uneven the picture still is:

• 31% of R&D labs are digitally siloed
• 34% are connected
• 11% are predictive
• 84% say a robust data foundation is essential to adopt new lab tech
• But only 37% track ROI with quantitative metrics 

Source: Deloitte

Investment and Funding in the Lab of the Future

Follow the money and the lab-of-the-future thesis stops looking speculative. Mega-rounds, government programs, and pharma budget shifts all point the same way.

Named funding events:

• Isomorphic Labs, Alphabet’s AI drug discovery arm, raised USD 600M in March 2025, then USD 2.1B in May 2026
  
• Xaira Therapeutics launched with USD 1B in 2024
  
• The US DOE’s ARPA-E committed USD 34M to 12 projects pairing AI with self-driving labs for catalyst development in April 2026

Sources: TechCrunch, 2025; PR Newswire, 2026, TechCrunch, ARPA-E, US DOE

Budget shifts inside pharma:

• Large pharma with over USD 10B in revenue is projected to invest about 7% of revenue in lab transformation by 2025, up from 4%
  
• 80% of R&D executives and 70% of QC executives plan to sustain or increase lab modernization investment 

Sources: Capgemini Research Institute, Deloitte

Lab Workforce and Adoption Barrier Statistics

The biggest blocker to the lab of the future isn’t the technology or the regulation. It’s people and plumbing, and the barrier data makes that plain.

What labs actually say is stopping them:

• 34% of labs cite a lack of people or skills as a barrier to AI adoption, up from 23% in 2024
  
• Only 9% now see regulation as a barrier to AI, down from 23% the prior year. Skills, not rules, are now the blocker.
  
• 45% of QC executives name poor integration between systems as the top barrier to modernization, ahead of competing priorities (38%), leadership support (38%), and ROI (32%) 

Sources: Pistoia Alliance, Deloitte

The underlying workforce shortage explains why skills top the list:

• The average clinical lab vacancy rate was 7.2% in the ASCP workforce survey, and US training programs graduate less than half the lab professionals the field needs each year

Source: ASCLS / ASCP 

The Sustainable Lab: Energy and Waste Statistics

The lab of the future is also a greener lab, mostly because today’s lab is a resource hog.

On energy:

• The 2024 Freezer Challenge saw 3,026 labs across 35 countries save 31.8M kWh, bringing cumulative savings to 76.5M kWh since 2017 

On waste:

• Biomedical and agricultural research generates roughly 5.5M tonnes of plastic waste per year
• Recycling lab plastics instead of incinerating them cuts emissions by 50–74%, and switching polystyrene deep-well plates to polypropylene cuts emissions by over 70% 

Sources: My Green Lab, Babraham Institute, Babraham Institute citing PLOS Sustainability & Transformation

Conclusion

That wraps up our roundup of 40+ statistics shaping the lab of the future.

The pattern across every theme is the same. The money, the market, and the intent are all racing ahead.

The reality on the bench is still catching up. Automation and AI deliver hard, measurable returns once they land, yet most labs are stuck in the messy middle, held back by data silos and a widening skills gap.

None of that changes the direction. The market is compounding at double digits and the investment keeps climbing.

But I reckon the gap will widen more unless we see a serious uptick in proper AI adoption in labs. 

Thanks for reading. If you found this roundup useful, take a look at our other statistics article on the unified lab platform. 

And for more independent lab tech articles like this one, subscribe to the BestLabTech newsletter. Every week we send a curated list of the most useful tools, resources, and reads from across the lab tech world. Enter your email below to subscribe.

Lab of the Future FAQ

What is the lab of the future?

The lab of the future is a connected, automated, AI-augmented, data-driven and more sustainable laboratory. In practice it is a maturity spectrum, not a single state: Deloitte finds 31% of R&D labs are still digitally siloed, 34% are connected, and only 11% are predictive (Source: Deloitte, 2025). Most labs are somewhere in the middle of that transition.

What role will AI play in the lab of the future?

AI is the central technology of the lab of the future, with 77% of life sciences labs expecting to use it within two years and AI ranked the number one investment area at 63% (Source: Pistoia Alliance, 2025). Deployment lags intent, though. Only 6% of QC labs operate at a predictive, AI-augmented maturity level today (Source: Deloitte, 2025).

How big is the lab automation market?

The global lab automation market is worth roughly USD 6.6B–10B in 2025/26 and is forecast to reach USD 8.6B–24B by the early-to-mid 2030s, across eight independent research firms with CAGRs of 4.9% to 10.4% (Source: MarketsandMarkets, 2026; SNS Insider, 2026). The wide spread reflects differing scope and methodology between firms.

What are the biggest barriers to the lab of the future?

The biggest barriers are integration, skills, and ROI, not technology or regulation. Deloitte finds 45% of QC executives name poor system integration as the top barrier (Source: Deloitte, 2025). The skills gap is cited by 34% of labs and rising, while only 9% now see regulation as a blocker (Source: Pistoia Alliance, 2025).